UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Annals of oncology, 2019-03, Vol.30 (3), p.397-404

2019

Volltextzugriff (PDF)

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Annals of oncology, 2016-04, Vol.27 (4), p.619-624

2016

Volltextzugriff (PDF)

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer

Annals of oncology, 2014-10, Vol.25 (10), p.1959-1965

2014

Volltextzugriff (PDF)

Is That Interference? A Work Flow for Identifying and Analyzing Communication Through Hydraulic Fractures in a Multiwell Pad

SPE journal (Society of Petroleum Engineers (U.S.) : 1996), 2016-10, Vol.21 (5), p.1554-1566

2016

Volltextzugriff (PDF)

Innovative perspectives of immunotherapy in head and neck cancer. From relevant scientific rationale to effective clinical practice

Cancer treatment reviews, 2016-02, Vol.43, p.113-123

2016

Volltextzugriff (PDF)

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Annals of oncology, 2014-04, Vol.25 (4), p.824-831

2014

Volltextzugriff (PDF)

Acarbose protects from central and peripheral metabolic imbalance induced by benzene exposure

Brain, behavior, and immunity, 2020-10, Vol.89, p.87-99

2020

Volltextzugriff (PDF)

Adjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate

Expert review of anticancer therapy, 2019-06, Vol.19 (6), p.447-454

2019

Volltextzugriff (PDF)

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy

Annals of oncology, 2013-01, Vol.24 (1), p.109-116

2013

Volltextzugriff (PDF)

Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials

Annals of oncology, 2023-01, Vol.34 (1), p.70-77

2023

Volltextzugriff (PDF)

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

British journal of cancer, 2015-06, Vol.113 (1), p.91-98

2015

Volltextzugriff (PDF)

Cooperative Learning and World-Readiness Standards for Learning Languages: A Guide for Effective Practice

1, 2022

Volltextzugriff (PDF)

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study

Supportive care in cancer, 2019-04, Vol.27 (4), p.1163-1170

2019

Volltextzugriff (PDF)

Pharmacological and non pharmacological treatment of Alzheimer's disease

Journal of the neurological sciences, 2019-10, Vol.405, p.73-74

Awada, A.

2019

Volltextzugriff (PDF)

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on 7 days off in patients with advanced, refractory solid tumours

British journal of cancer, 2005-05, Vol.92 (10), p.1855-1861

2005

Volltextzugriff (PDF)

How do cancer centres communicate clinical trials opportunities to patients on their websites?

European journal of cancer (1990), 2017-02, Vol.72, p.S132-S132

2017

Volltextzugriff (PDF)

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Annals of oncology, 2010-02, Vol.21 (2), p.275-282

2010

Volltextzugriff (PDF)

Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

Annals of oncology, 2012-07, Vol.23 (7), p.1687-1693

2012

Volltextzugriff (PDF)

How I treat endocrine-dependent metastatic breast cancer

ESMO open, 2023-04, Vol.8 (2), p.100882, Article 100882

2023

Volltextzugriff (PDF)

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

Annals of oncology, 2017-09, Vol.28 (9), p.2219-2224

2017

Volltextzugriff (PDF)

PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii20-viii20

2018

Volltextzugriff (PDF)

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis

ESMO open, 2022-06, Vol.7 (3), p.100501-100501, Article 100501

2022

Volltextzugriff (PDF)

Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial

Annals of oncology, 2018-10, Vol.29, p.viii57-viii57

2018

Volltextzugriff (PDF)

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer

ESMO open, 2022-12, Vol.7 (6), p.100651, Article 100651

2022

Volltextzugriff (PDF)

M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients (pts) with advanced SCCHN: Results from a phase I cohort

Annals of oncology, 2018-10, Vol.29, p.viii373-viii373

2018

Volltextzugriff (PDF)

1 – 25 von 2.564

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.162)
Mit Volltextzugriff
(2.123)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(126)
Journal Of Clinical Oncology
(124)
Annals Of Oncology
(93)
Cancer Research
(76)
European Journal Of Cancer
(59)
Revue Neurologique
(58)
Current Opinion In Oncology
(41)
Yakugaku Zasshi
(37)
Physics Letters. B
(27)
European Journal Of Cancer Supplements
(25)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer

Is That Interference? A Work Flow for Identifying and Analyzing Communication Through Hydraulic Fractures in a Multiwell Pad

Innovative perspectives of immunotherapy in head and neck cancer. From relevant scientific rationale to effective clinical practice

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Acarbose protects from central and peripheral metabolic imbalance induced by benzene exposure

Adjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy

Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

Cooperative Learning and World-Readiness Standards for Learning Languages: A Guide for Effective Practice

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study

Pharmacological and non pharmacological treatment of Alzheimer's disease

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on 7 days off in patients with advanced, refractory solid tumours

How do cancer centres communicate clinical trials opportunities to patients on their websites?

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

How I treat endocrine-dependent metastatic breast cancer

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis

Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer

M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients (pts) with advanced SCCHN: Results from a phase I cohort

Suchergebnisse filtern